Sorrento granted FDA clearance to start late-stage trial for COVID-19 therapy
March 31 2022 - 9:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Apr 2024 to May 2024
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From May 2023 to May 2024